We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




US Patent Allows Full-Body MRI Technology for Use with Pacemakers

By HospiMedica International staff writers
Posted on 24 Apr 2014
A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker.

Cardiothoracic surgeon Raymond Schaerf, MD implanted the Accent MRI pacemaker and Tendril MRI lead in an 82-year-old patient, who successfully MRI scanning. More...
Led by Dr. Schaerf, from Providence Saint Joseph Medical Center (Burbank, CA, USA), was part a global clinical study to help determine if a patient can safely and effectively undergo a full-body, high-resolution MRI scan with the Accent MRI system.

Many patients with pacemakers and defibrillators require MRI studies to help with their care and diagnoses, according to Dr. Schaerf, a leader in the study of MRI use on patients with implanted devices including pacemakers and defibrillators. The Accent pacemaker was designed to be compatible with MRI, frequently the favored diagnostic approach for certain medical disorders such as cancer, stroke, spine and neurologic disorders.

“We have been privileged to have done more than 400 MRI studies through an FDA [US Food and Drug Administration]-approved study over the last six years, but are restricted in what studies can be performed,” Dr. Schaerf said. “With this device and system, we have made a great leap forward, and in this patient actually did an MRI of the heart, with no problems and no artifacts on the scan caused by metal.”

The investigational Accent MRI pacemaker and Tendril MRI lead can be used for full-body scans without any anatomical restrictions because of technology designed to protect a patient from the risks associated with an MRI setting.

The Accent MRI Pacemaker and Tendril MRI lead, developed by St. Jude Medical (St. Paul, MN, USA), are available in Europe and Japan. In March 2012, St. Jude Medical received conditional investigational device exemption approval from the US Food and Drug Administration to start enrollment in this clinical study.

Related Links:

Providence Saint Joseph Medical Center
St. Jude Medical



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Infrared Digital Thermometer
R1B1
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.